RBC Capital Markets raised its price target on Cameco (CCO.TO, CCJ) to C$175 from C$160 on Monday.
Analyst Andrew D. Wong maintained an Outperform rating on shares of the Saskatchewan-based uranium company.
"We continue to see Cameco as best-positioned to benefit from strong nuclear growth momentum and a constructive uranium price outlook," the analyst said.